Patents by Inventor Bart Claes

Bart Claes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240035075
    Abstract: The field of the invention generally relates to detection of nucleic acid targets in a multiplex reaction setting. In particular, disclosed herein are methods, kits, kits of parts, systems or components thereof for performing a multiplex PCR detection using custom genetic target panels in a generic detection cartridge. The disclosed methods and kits can typically be utilized for quickly designing automated multiplex PCR-based detection assays for a large number, i.e. tens or multiples of tens, of personalized and/or customized genetic targets, including mutations, SNPs, pathogenic sequences, epigenetic lesions etc.
    Type: Application
    Filed: October 29, 2021
    Publication date: February 1, 2024
    Inventors: Benoit Devogelaere, Bart Claes, Thomas Piofczyk
  • Publication number: 20210246499
    Abstract: The present application relates to detection of changes in the number of nucleotides in short homopolymeric nucleic acid repeats, in particular in short homopolymeric microsatellites, for example for the purpose of diagnosing microsatellite instability (MSI) and/or mismatch repair (MMR-) deficiency in tumors. Accordingly, methods are provided for detecting changes in the number of nucleotides present in short homopolymeric nucleotide repeat sequences as well as kits and cartridges for automated detection of said changes.
    Type: Application
    Filed: April 26, 2021
    Publication date: August 12, 2021
    Applicant: Biocartis NV
    Inventors: Bart Claes, Rudi Rossau
  • Patent number: 11028431
    Abstract: The present application relates to detection of changes in the number of nucleotides in short homopolymeric nucleic acid repeats, in particular in short homopolymeric microsatellites, for example for the purpose of diagnosing microsatellite instability (MSI) and/or mismatch repair (MMR-) deficiency in tumors. Accordingly, methods are provided for detecting changes in the number of nucleotides present in short homopolymeric nucleotide repeat sequences as well as kits and cartridges for automated detection of said changes.
    Type: Grant
    Filed: September 22, 2016
    Date of Patent: June 8, 2021
    Assignee: BIOCARTIS, NV
    Inventors: Bart Claes, Rudi Rossau
  • Patent number: 10196673
    Abstract: Improved compositions for and methods of processing and analyzing samples are described. In particular, the compositions and methods liberate nucleic acids from a biological sample allowing direct downstream processing of the nucleic acids in microfluidic systems. These compositions, methods and kits are useful in diagnosing, staging or otherwise characterizing various biological conditions.
    Type: Grant
    Filed: February 18, 2014
    Date of Patent: February 5, 2019
    Assignee: BIOCARTIS N.V.
    Inventors: Koen Van Acker, Bart Claes, Benoit Devogelaere, Geert Maertens, Erwin Sablon, Pascale Holemans, Tania Ivens
  • Publication number: 20180371537
    Abstract: The present application relates to detection of changes in the number of nucleotides in short homopolymeric nucleic acid repeats, in particular in short homopolymeric microsatellites, for example for the purpose of diagnosing microsatellite instability (MSI) and/or mismatch repair (MMR-) deficiency in tumors. Accordingly, methods are provided for detecting changes in the number of nucleotides present in short homopolymeric nucleotide repeat sequences as well as kits and cartridges for automated detection of said changes.
    Type: Application
    Filed: September 22, 2016
    Publication date: December 27, 2018
    Applicant: Biocartis NV
    Inventors: Bart Claes, Rudi Rossau
  • Publication number: 20160002706
    Abstract: Improved compositions for and methods of processing and analyzing samples are described. In particular, the compositions and methods liberate nucleic acids from a biological sample allowing direct downstream processing of the nucleic acids in microfluidic systems. These compositions, methods and kits are useful in diagnosing, staging or otherwise characterizing various biological conditions.
    Type: Application
    Filed: February 18, 2014
    Publication date: January 7, 2016
    Inventors: Koen Van Acker, Bart Claes, BenoƮt Devogelaere, Geert Maertens, Erwin Sablon, Pascale Holemans, Tania Ivens